Sun Pharmaceutical Industries Ltd.
Deferasirox-defrijet
"Deferasirox" is the Drug / Molecule content in "Defrijet". Deferasirox is mainly used to reduce chronic ieon overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemia's.
Indication
Defrijet is used in the treatment of chronic iron overload in transfusional hemosiderosis.
Note
Precaution
- Defrijet is a prescription drug and should be used under proper medical guidance and advice.
- Monitor renal function and CBC before starting the medication and regularly during the treatment.
Updated On Oct 25, 2019 by Admin
Strength
100 mg & 400 mg
Packing
1 X 6 Tablets (Strip)
Storage
Store in a cool, dry place, protected from sunlight and moisture.
Was this page helpful?
Most Viewed Products
CIPLA LTD. (INDIA)
Abiraterone acetate-xbira
NATCO PHARMA LIMITED (INDIA)
Bendamustine-bendit
CIPLA LTD. (INDIA)
Bicalutamide-cassotide
NATCO PHARMA LIMITED (INDIA)
Bortezomib-bortenat
NATCO PHARMA LIMITED (INDIA)
Erlonat
Biocon Limited
Everolimus-evertor
NATCO PHARMA LIMITED (INDIA)
Exemestane-xtane
NATCO PHARMA LIMITED (INDIA)
Geftinat
NATCO PHARMA LIMITED (INDIA)
Glatiramer acetate-glatimer
NATCO PHARMA LIMITED (INDIA)
Ledipasvir & sofosbuvir-hepcinat lp
NATCO PHARMA LIMITED (INDIA)
Lenalidomide-lenalid
NATCO PHARMA LIMITED (INDIA)
Pomalidomide-pomalid
NATCO PHARMA LIMITED (INDIA)
Sofosbuvir & velpatasvir-velpanat
NATCO PHARMA LIMITED (INDIA)
Sorafenib-sorafenat
CIPLA LTD. (INDIA)